Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia

Jeffrey P. Sharman; Kathryn S. Kolibaba; Jose Azar; Rama Balaraman; Roger M. Lyons; Mitchell R. Smith; Esteban Abella-Dominicis; Wei Ye; Wen Shi; Thomas Giever; Andres Forero-Torres

doi:10.1182/BLOOD.V130.SUPPL_1.832.832

Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia

Jeffrey P. Sharman
, Kathryn S. Kolibaba
, Jose Azar
, Rama Balaraman
, Roger M. Lyons
, Mitchell R. Smith
, Esteban Abella-Dominicis
, Wei Ye
, Wen Shi
, Thomas Giever
, Andres Forero-Torres

Willamette University
Northwest Cancer Specialists, US Oncology Research, Vancouver, WA
Indiana University
Florida Cancer Affiliates, US Oncology Research, Ocala, FL
Texas Oncology
Cleveland Clinic
Gilead Sciences, Inc., Foster City, CA
Virginia Mason Memorial North Star Lodge, Yakima, WA
University of Alabama at Birmingham

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	130
DOIs	https://doi.org/10.1182/BLOOD.V130.SUPPL_1.832.832
State	Published - Dec 7 2017
Externally published	Yes

Disciplines

Medicine and Health Sciences
Internal Medicine

Access to Document

10.1182/BLOOD.V130.SUPPL_1.832.832License: Unspecified

Cite this

@article{30b2baf37da0422597f6e2d9d06d9f60,

title = "Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia",

author = "Sharman, \{Jeffrey P.\} and Kolibaba, \{Kathryn S.\} and Jose Azar and Rama Balaraman and Lyons, \{Roger M.\} and Smith, \{Mitchell R.\} and Esteban Abella-Dominicis and Wei Ye and Wen Shi and Thomas Giever and Andres Forero-Torres",

note = "642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT | Jeffrey P. Sharman, Kathryn S. Kolibaba, Jose Azar, Rama Balaraman, Roger M. Lyons, Mitchell R. Smith, Esteban Abella-Dominicis, Wei Ye, Wen Shi, Thomas Giever, Andres Forero-Torres; Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia.",

year = "2017",

month = dec,

day = "7",

doi = "10.1182/BLOOD.V130.SUPPL\_1.832.832",

language = "American English",

volume = "130",

journal = "Blood",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia

AU - Sharman, Jeffrey P.

AU - Kolibaba, Kathryn S.

AU - Azar, Jose

AU - Balaraman, Rama

AU - Lyons, Roger M.

AU - Smith, Mitchell R.

AU - Abella-Dominicis, Esteban

AU - Ye, Wei

AU - Shi, Wen

AU - Giever, Thomas

AU - Forero-Torres, Andres

N1 - 642. CLL: Therapy, excluding Transplantation: New Agents, Infections, and PET/CT | Jeffrey P. Sharman, Kathryn S. Kolibaba, Jose Azar, Rama Balaraman, Roger M. Lyons, Mitchell R. Smith, Esteban Abella-Dominicis, Wei Ye, Wen Shi, Thomas Giever, Andres Forero-Torres; Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia.

PY - 2017/12/7

Y1 - 2017/12/7

UR - https://ashpublications.org/blood/article/130/Suppl_1/832/83682/Evaluating-the-Efficacy-Safety-and-Dose-Dependent

U2 - 10.1182/BLOOD.V130.SUPPL_1.832.832

DO - 10.1182/BLOOD.V130.SUPPL_1.832.832

M3 - Article

VL - 130

JO - Blood

JF - Blood

ER -

Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia

Disciplines

Access to Document

Other files and links

Cite this